Cited by 917Pancreatic function and diabetesDiabetes Treatment and ManagementDiabetes Management and Research

The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.

Plasma Insulin Responses to Oral and Intravenous Glucose: Studies in Normal and Diabetic Subjects*

Open access

Perley, Michael J., Kipnis, David M.·1967·Journal of Clinical Investigation

Open this paper in CoChat — free account Open PDF

Abstract

The plasma insulin responses of normal weight and obese, diabetic, and nondiabetic subjects to intravenous glucose was only 30-40% of that seen after oral glucose, indicating that alimentary mechanism(s) in addition to the arterial blood sugar concentration regulate insulin secretion. Observations made in subjects with diverted portal circulation indicate that the alimentary insulinogenic mechanism is located in the intestinal tract. The insulinogenic potency of the alimentary and glycemic stimuli expressed in terms of insulin secretion per gram of glucose were remarkably similar within each group of individuals. Between these groups, however, there were considerable differences. Obesity, with or without associated diabetes, was associated with a true hypersecretory responsiveness, whereas diabetes was characterized, with or without obesity, by a marked impairment in insulin secretion. The experimental design used in these studies permitted quantitation of the magnitude of the glycemic component of an oral glucose load. As a consequence of impaired insulin secretion, a greater than normal proportion of the oral glucose load escapes initial hepatic extraction in the maturity-onset diabetic and enters the peripheral circulation. Therefore, in the noninsulin-requiring maturity-onset diabetic, the glycemic insulinogenic stimulus for a given oral glucose load is significantly greater than in normal subjects and accounts for the excessive plasma insulin responses observed late in the course of an oral glucose tolerance test.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1172/jci105685

Cites

24 of 24 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

DETERMINATION OF BLOOD SUGAR
Somogyi, M. (1945) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)43098-0 · Cited by 1,788
Plasma Insulin Response to Oral and Intravenous Glucose Administration1
ELRICK, H., STIMMLER, L., HLAD, C. J., & ARAI, Y. (1964) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-24-10-1076 · Cited by 857
Insulin Secretion in Response to Glycemic Stimulus: Relation of Delayed Initial Release to Carbohydrate intolerance in Mild Diabetes Mellitus*
Seltzer, H. S., Allen, E. W., Herron, A. L., & Brennan, M. T. (1967) · Journal of Clinical Investigation · doi:10.1172/jci105534 · Cited by 819 · cited 1×
“(24) and Cerasi and Luft (25) that insulin secretion is impaired in diabetes mellitus.”
Background
New Interpretation of Oral Glucose Tolerance
Mcintyre, N., Holdsworth, C. D., & Turner, D. S. (1964) · The Lancet · doi:10.1016/s0140-6736(64)90011-x · Cited by 738
Promotion of Insulin Secretion by Glucagon
Samols, E., Marri, G., & Marks, V. (1965) · The Lancet · doi:10.1016/s0140-6736(65)90761-0 · Cited by 521
Intestinal Factors in the Control of Insulin Secretion
McIntyre, N., Holdsworth, C. D., & Turner, D. S. (1965) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-25-10-1317 · Cited by 382
THE PLASMA INSULIN RESPONSE TO GLUCOSE INFUSION IN HEALTHY SUBJECTS AND IN DIABETES MELLITUS
Cerasi, E., & Luft, R. (1967) · Acta Endocrinologica · doi:10.1530/acta.0.0550278 · Cited by 371
Plasma insulin responses to glucose and tolbutamide of normal weight and obese diabetic and nondiabetic subjects
Perley, M., & Kipnis, D. M. (1966) · Diabetes · doi:10.2337/diab.15.12.867 · Cited by 330
Self-citation
Plasma Insulin Concentrations in Nondiabetic and Early Diabetic Subjects: Determinations by a New Sensitive Immuno-assay Technic
Yalow, R. S., & Berson, S. A. (1960) · Diabetes · doi:10.2337/diab.9.4.254 · Cited by 330
PLASMA INSULIN AND GROWTH HORMONE LEVELS IN OBESITY AND DIABETES
Yalow, R. S., Glick, S. M., Roth, J., & Berson, S. A. (1965) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1965.tb34803.x · Cited by 199

Flagged first, then by citations

Show all 24 references

Sorted by citations

Items 101–200 of 914

Initial splanchnic extraction of ingested glucose in normal man
Radziuk, J., McDonald, T. J., Rubenstein, D., & Dupre, J. (1978) · Metabolism · doi:10.1016/0026-0495(78)90003-3 · Cited by 207
Physiologic relevance of heterogeneity in the pancreatic beta-cell population
PIPELEERS, D. G., Kiekens, R., Ling, Z., Wilikens, A., & Schuit, F. C. (1994) · Diabetologia · doi:10.1007/bf00400827 · Cited by 150
Endocrine and Metabolic Adaptation to Obesity and Starvation
Sims, E. A. H., & Horton, E. S. (1968) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/21.12.1455 · Cited by 149
From the Incretin Concept and the Discovery of GLP-1 to Today's Diabetes Therapy
Holst, J. J. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00260 · Cited by 153
Obesity and its comorbidities, current treatment options and future perspectives: Challenging bariatric surgery?
Kloock, S., Ziegler, C. G., & Dischinger, U. (2023) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2023.108549 · Cited by 173
HDL and LDL cholesterol significantly influence β-cell function in type 2 diabetes mellitus
Kruit, J. K., Brunham, L. R., Verchere, C. B., & Hayden, M. R. (2010) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e328339387b · Cited by 148
Crosstalk between diabetes and brain: Glucagon-like peptide-1 mimetics as a promising therapy against neurodegeneration
Duarte, A. I., Candeias, E., Correia, S. C., Santos, R. X., Carvalho, C., Cardoso, S., Plácido, A. I., Santos, M. S., Oliveira, C. R., & Moreira, P. I. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2013.01.008 · Cited by 149
Relationship between insulin sensitivity, insulin secretion and glucose tolerance in cirrhosis
Kruszynska, Y. T., Home, P. D., & McIntyre, N. (1991) · Hepatology · doi:10.1002/hep.1840140117 · Cited by 142
β-Cell Deficit Due to Increased Apoptosis in the Human Islet Amyloid Polypeptide Transgenic (HIP) Rat Recapitulates the Metabolic Defects Present in Type 2 Diabetes
Matveyenko, A. V., & Butler, P. C. (2006) · Diabetes · doi:10.2337/db05-1672 · Cited by 144
Classification and Diagnosis of Diabetes Mellitus
GENUTH, S. M. (1982) · Medical Clinics of North America · doi:10.1016/s0025-7125(16)31358-x · Cited by 140
Secretion of incretin hormones (GIP and GLP-1) and incretin effect after oral glucose in first-degree relatives of patients with type 2 diabetes
Nauck, M. A., El-Ouaghlidi, A., Gabrys, B., Hücking, K., Holst, J. J., Deacon, C. F., Gallwitz, B., Schmidt, W. E., & Meier, J. J. (2004) · Regulatory Peptides · doi:10.1016/j.regpep.2004.06.020 · Cited by 137
Portal Diversion for the Treatment of Glycogen Storage Disease in Humans
Starzl, T. E., PUTNAM, C. W., PORTER, K. A., HALGRIMSON, C. C., Corman, J., Brown, B. I., COTLIN, R. W., RODCERSON, D. O., & CREENE, H. L. (1973) · Annals of Surgery · doi:10.1097/00000658-197310000-00015 · Cited by 136
Cholesterol efflux via ATP-binding cassette transporter A1 (ABCA1) and cholesterol uptake via the LDL receptor influences cholesterol-induced impairment of beta cell function in mice
Kruit, J. K., Kremer, P. H. C., Dai, L., Tang, R., Ruddle, P., de Haan, W., Brunham, L. R., Verchere, C. B., & Hayden, M. R. (2010) · Diabetologia · doi:10.1007/s00125-010-1691-2 · Cited by 133
Loss of beta cell function as fasting glucose increases in the non-diabetic range
Godsland, I. F., Jeffs, J. A. R., & Johnston, D. G. (2004) · Diabetologia · doi:10.1007/s00125-004-1454-z · Cited by 131
Metabolic basis of obesity and noninsulin‐dependent diabetes mellitus
Golay, A., Jp, F., Jéquier, E., DeFronzo, R. A., & Ferrannini, E. (1988) · Diabetes/Metabolism Reviews · doi:10.1002/dmr.5610040803 · Cited by 130
A review of carbohydrate metabolism and the oral contraceptives
Spellacy, W. N. (1969) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(16)34204-1 · Cited by 130
The Biology of Glucagon and the Consequences of Hyperglucagonemia
Albrechtsen, N. J. W., Kuhre, R. E., Pedersen, J., Knop, F. K., & Holst, J. J. (2016) · Biomarkers in Medicine · doi:10.2217/bmm-2016-0090 · Cited by 132
Differential Effects of Hyperlipidemia on Insulin Secretion in Islets of Langerhans From Hyperglycemic Versus Normoglycemic Rats
Briaud, I., Kelpe, C. L., Johnson, L. M., Tran, P. O. T., & Poitout, V. (2002) · Diabetes · doi:10.2337/diabetes.51.3.662 · Cited by 127
The Role of Incretins on Insulin Function and Glucose Homeostasis
Holst, J. J., Gasbjerg, L. S., & ROSENKILDE, M. M. (2021) · Endocrinology · doi:10.1210/endocr/bqab065 · Cited by 141
Effect of endogenous GLP-1 on insulin secretion in type 2 diabetes
Salehi, M., Aulinger, B., Prigeon, R. L., & D'Alessio, D. A. (2010) · Diabetes · doi:10.2337/db09-1253 · Cited by 124
Nutrient detection by incretin hormone secreting cells
Diakogiannaki, E., Gribble, F. M., & Reimann, F. M. (2011) · Physiology & Behavior · doi:10.1016/j.physbeh.2011.12.001 · Cited by 132
Dipeptidyl peptidase-4 inhibitors for the treatment of type 2 diabetes: comparison, efficacy and safety
Deacon, C. F., & Holst, J. J. (2013) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2013.824966 · Cited by 127
Elimination of the action of glucagon-like peptide 1 causes an impairment of glucose tolerance after nutrient ingestion by healthy baboons.
D’Alessio, D. A., Vogel, R., Prigeon, R. L., Laschansky, E. C., Koerker, D. J., Eng, J., & Ensinck, J. W. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118380 · Cited by 119
The gastrointestinal stimulus to insulin release
Chisholm, D. J., Young, J. D., & Lazarus, L. (1969) · Journal of Clinical Investigation · doi:10.1172/jci106111 · Cited by 122
Glucose Intolerance and Insulin Resistance in Patients With Liver Disease
Collins, J. R. (1969) · Archives of Internal Medicine · doi:10.1001/archinte.1969.00300180014003 · Cited by 125
Distinct Effects of Glucose-Dependent Insulinotropic Polypeptide and Glucagon-Like Peptide-1 on Insulin Secretion and Gut Motility
Miki, T., Minami, K., Shinozaki, H., Matsumura, K., Saraya, A., Ikeda, H., Yamada, Y., Holst, J. J., & Seino, S. (2005) · Diabetes · doi:10.2337/diabetes.54.4.1056 · Cited by 117
The Glucose Uptake of Human Adipose Tissue in Obesity
Bjöentorp, P., Berchtold, P., Holm, J., & Larsson, B. (1971) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.1971.tb00559.x · Cited by 120
Abnormal meal carbohydrate disposition in insulin-dependent diabetes. Relative contributions of endogenous glucose production and initial splanchnic uptake and effect of intensive insulin therapy.
Pehling, G., Tessari, P., Gerich, J., Haymond, M., Service, F., & Rizza, R. (1984) · Journal of Clinical Investigation · doi:10.1172/jci111519 · Cited by 132
Roles of cAMP signalling in insulin granule exocytosis
Seino, S., Takahashi, H., Fujimoto, W., & Shibasaki, T. (2009) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2009.01108.x · Cited by 117
The effect of fasting, diet, and actinomycin D on insulin secretion in the rat
Grey, N. J., Goldring, S. R., & KIPNIS, D. M. (1970) · Journal of Clinical Investigation · doi:10.1172/jci106307 · Cited by 115
Self-citation
Cardiometabolic-Based Chronic Disease, Addressing Knowledge and Clinical Practice Gaps
Mechanick, J. I., Farkouh, M. E., Newman, J. D., & Garvey, W. T. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2019.11.046 · Cited by 113
Influence of hyperglycemia on insulin's in vivo effects in type II diabetes.
REVERS, R. R., Fink, R. I., Griffin, J., Olefsky, J. M., & Kolterman, O. (1984) · Journal of Clinical Investigation · doi:10.1172/jci111258 · Cited by 113
Incretin hormone mimetics and analogues in diabetes therapeutics
Green, B. D., & Flatt, P. R. (2007) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2007.09.003 · Cited by 115
Carbohydrate Homeostasis
Levine, R., & Haft, D. E. (1970) · New England Journal of Medicine · doi:10.1056/nejm197007232830405 · Cited by 114
Differential effects of acute and extended infusions of glucagon-like peptide-1 on first- and second-phase insulin secretion in diabetic and nondiabetic humans
Quddusi, S., Vahl, T. P., Hanson, K., Prigeon, R. L., & D’Alessio, D. A. (2003) · Diabetes Care · doi:10.2337/diacare.26.3.791 · Cited by 111
G Protein–Coupled Receptors Targeting Insulin Resistance, Obesity, and Type 2 Diabetes Mellitus
Riddy, D. M., Delerive, P., Summers, R. J., Sexton, P. M., & Langmead, C. J. (2018) · Pharmacological Reviews · doi:10.1124/pr.117.014373 · Cited by 108
Short Chain Fatty Acids, pancreatic dysfunction and type 2 diabetes
Mandaliya, D. K., & Seshadri, S. (2019) · Pancreatology · doi:10.1016/j.pan.2019.01.021 · Cited by 112
Pancreas islets in metabolic signaling - focus on the beta-cell
Suckale, J. (2008) · Frontiers in bioscience · doi:10.2741/3218 · Cited by 117
Decrease in β-Cell Mass Leads to Impaired Pulsatile Insulin Secretion, Reduced Postprandial Hepatic Insulin Clearance, and Relative Hyperglucagonemia in the Minipig
Kjems, L., Kirby, B. M., Welsh, E. M., Veldhuis, J. D., Straume, M., McIntyre, S. S., Yang, D., Lefèbvre, P., & Butler, P. C. (2001) · Diabetes · doi:10.2337/diabetes.50.9.2001 · Cited by 108
Dipeptidyl peptidase‐IV inhibitors: a major new class of oral antidiabetic drug
IDRIS, I. R., & Donnelly, R. (2007) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2007.00705.x · Cited by 113
Emerging Therapies Mimicking the Effects of Amylin and Glucagon-Like Peptide 1
Riddle, M. C., & Drucker, D. J. (2006) · Diabetes Care · doi:10.2337/diacare.29.02.06.dc05-1267 · Cited by 108
Plasma Insulin and Glucose Profiles in Normal, Obese, and Diabetic Persons
GENUTH, S. M. (1973) · Annals of Internal Medicine · doi:10.7326/0003-4819-79-6-812 · Cited by 109
Defective glucose counterregulation after subcutaneous insulin in noninsulin-dependent diabetes mellitus. Paradoxical suppression of glucose utilization and lack of compensatory increase in glucose production, roles of insulin resistance, abnormal neuroendocrine responses, and islet paracrine interactions.
Bolli, G. B., Tsalikian, E., Haymond, M. W., Cryer, P. E., & Gerich, J. E. (1984) · Journal of Clinical Investigation · doi:10.1172/jci111359 · Cited by 108
Targeting β-Cell Mass in Type 2 Diabetes: Promise and Limitations of New Drugs Based on Incretins
Salehi, M., Aulinger, B. A., & D’Alessio, D. A. (2008) · Endocrine Reviews · doi:10.1210/er.2007-0031 · Cited by 107
Targeting β-Cell Function Early in the Course of Therapy for Type 2 Diabetes Mellitus
Leahy, J. L., Hirsch, I. B., PETERSON, K. A., & Schneider, D. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-0668 · Cited by 110
Relationship between two stages of prandial insulin release in rats.
LOUIS-SYLVESTRE, J. (1978) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1978.235.2.e103 · Cited by 108
Gut Hormones and Their Effect on Bone Metabolism. Potential Drug Therapies in Future Osteoporosis Treatment
Schiellerup, S. P., Skov‐Jeppesen, K., Windeløv, J. A., Svane, M. S., Holst, J. J., Hartmann, B., & ROSENKILDE, M. M. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00075 · Cited by 110
Therapeutic potential for GIP receptor agonists and antagonists
Irwin, N., & Flatt, P. R. (2009) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2009.03.001 · Cited by 105
The role of fractional glucose extraction in the regulation of splanchnic glucose metabolism in normal and diabetic man
Ferrannini, E., Wahren, J., Felig, P., & DeFronzo, R. A. (1980) · Metabolism · doi:10.1016/0026-0495(80)90094-3 · Cited by 107
Importance of Early Phase Insulin Secretion to Intravenous Glucose Tolerance in Subjects with Type 2 Diabetes Mellitus
Kahn, S. E., Montgomery, B. K., Howell, W., Ligueros‐Saylan, M., Hsu, C., Devineni, D., McLeod, J. F., Horowitz, A. D., & Foley, J. E. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.12.8105 · Cited by 105
The [pre-] history of the incretin concept
Creutzfeldt, W. (2004) · Regulatory Peptides · doi:10.1016/j.regpep.2004.08.004 · Cited by 104
Human Adipose Tissue Dynamics and Regulation
Björntorp, P. A., & Östman, J. (1971) · Advances in metabolic disorders · doi:10.1016/b978-0-12-027305-8.50027-8 · Cited by 104
Cirrhosis and diabetes
Conn, H. O., Schreiber, W., & Elkington, S. G. (1971) · Digestive Diseases and Sciences · doi:10.1007/bf02235244 · Cited by 101
The Origin and Understanding of the Incretin Concept
Rehfeld, J. F. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00387 · Cited by 102
Gastric Inhibitory Polypeptide Release after Oral Glucose: Relationship to Glucose Intolerance, Diabetes Mellitus, and Obesity
Salera, M., Giacomoni, P., Pironi, L., Cornia, G. L., Capelli, M., Marini, A. M., Benfenati, F., Miglioli, M., & Barbara, L. (1982) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-55-2-329 · Cited by 101
Metabolic effects of oral glucose in the liver of fasted rats
Niewoehner, C. B., Gilboe, D. P., & Nuttall, F. Q. (1984) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1984.246.1.e89 · Cited by 99
Glucose-dependent insulinotropic polypeptide (GIP): anti-diabetic and anti-obesity potential?
Gault, V. A., O'Harte, F. P. M., & Flatt, P. R. (2003) · Neuropeptides · doi:10.1016/j.npep.2003.09.002 · Cited by 102
Successful Versus Failed Adaptation to High-Fat Diet–Induced Insulin Resistance
Matveyenko, A. V., Gurlo, T., Daval, M., Butler, A. E., & Butler, P. C. (2009) · Diabetes · doi:10.2337/db08-1464 · Cited by 98
DIABETES: THE QUEST FOR BASAL NORMOGLYCÆMIA
Holman, R. R., & Turner, R. C. (1977) · The Lancet · doi:10.1016/s0140-6736(77)91954-7 · Cited by 97
1Carbohydrate metabolism in vivo: Regulation of the blood glucose level
Newsholme, E. A. (1976) · Clinics in Endocrinology and Metabolism · doi:10.1016/s0300-595x(76)80040-0 · Cited by 96
Disorderly and nonstationary insulin secretion in relatives of patients with NIDDM
Schmitz, O., Pørksen, N. K., Nyholm, B., Skjærbæk, C. B., Butler, P. C., Veldhuis, J. D., & Pincus, S. M. (1997) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1997.272.2.e218 · Cited by 95
The Different Effects on the Serum Lipids and Fecal Steroids of High Carbohydrate Diets Given Orally or Intravenously
DenBesten, L., Reyna, R., Connor, W. E., & Stegink, L. D. (1973) · Journal of Clinical Investigation · doi:10.1172/jci107311 · Cited by 94
Impaired glucose tolerance (IGT) is associated with reduced insulin-induced suppression of glucagon concentrations
Ahr�n, B., & Larsson, H. (2001) · Diabetologia · doi:10.1007/s001250100003 · Cited by 95
Glucose storage and oxidation in different degrees of human obesity measured by continuous indirect calorimetry
Felber, J. P., Meyer, H. U., Curchod, B., Iselin, H. U., Rousselle, J., Maeder, E., Pahud, P., & Jéquier, E. (1981) · Diabetologia · doi:10.1007/bf00253814 · Cited by 95
Glucagon-like peptide 1 (GLP-1): a potent gut hormone with a possible therapeutic perspective
Nauck, M. A. (1998) · Acta Diabetologica · doi:10.1007/s005920050116 · Cited by 94
The effects of kisspeptin on β‐cell function, serum metabolites and appetite in humans
Izzi‐Engbeaya, C. N., Comninos, A. N., Clarke, S. A., Jomard, A., Yang, L. Y., Jones, S., Abbara, A., Narayanaswamy, S., Eng, P. C., Papadopoulou, D., et al. (2018) · Diabetes Obesity and Metabolism · doi:10.1111/dom.13460 · Cited by 93
The Changing Landscape of Diabetes Therapy for Cardiovascular Risk Reduction
Newman, J. D., Vani, A. K., Alemán, J. O., WEINTRAUB, H. S., Berger, J. S., & Schwartzbard, A. Z. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.07.071 · Cited by 95
Stimulation of incretin secreting cells
Pais, R., Gribble, F. M., & Reimann, F. M. (2015) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/2042018815618177 · Cited by 105
Incretins and the development of type 2 diabetes
Meier, J. J., & Nauck, M. A. (2006) · Current Diabetes Reports · doi:10.1007/s11892-006-0034-7 · Cited by 96
The incretin hormone GLP‐1 and mechanisms underlying its secretion
Tian, L., & Jin, T. (2016) · Journal of Diabetes · doi:10.1111/1753-0407.12439 · Cited by 99
Insulin Insensitivity of Large Fat Cells
Livingston, J. N., Cuatrecasas, P., & Lockwood, D. H. (1972) · Science · doi:10.1126/science.177.4049.626 · Cited by 94
Glucose-dependent insulinotropic polypeptide (GIP)
Müller, T. D., Adriaenssens, A. E., Ahrén, B., Blüher, M., Birkenfeld, A. L., Campbell, J. E., Coghlan, M. P., D’Alessio, D. D., Deacon, C. F., DelPrato, S., et al. (2025) · Molecular Metabolism · doi:10.1016/j.molmet.2025.102118 · Cited by 103
K-cells and Glucose-Dependent Insulinotropic Polypeptide in Health and Disease
Cho, Y. M., & Kieffer, T. J. (2010) · Vitamins and hormones · doi:10.1016/b978-0-12-381517-0.00004-7 · Cited by 98
Influence of Gastric Inhibitory Polypeptide Antiserum on Glucose-Induced Insulin Secretion in Rats
Ebert, R., & Creutzfeldt, W. (1982) · Endocrinology · doi:10.1210/endo-111-5-1601 · Cited by 93
Defining the Role of GLP-1 in the Enteroinsulinar Axis in Type 2 Diabetes Using DPP-4 Inhibition and GLP-1 Receptor Blockade
Aulinger, B. A., Bedorf, A., Kutscherauer, G., de Heer, J., Holst, J. J., Göke, B., & Schirra, J. R. J. (2013) · Diabetes · doi:10.2337/db13-1455 · Cited by 91
Impact of differences in fasting glucose and glucose tolerance on the hyperbolic relationship between insulin sensitivity and insulin responses.
Utzschneider, K., Prigeon, R., Carr, D., Hull, R., Tong, J., Shofer, J., Retzlaff, B., Knopp, R., & Kahn, S. (2006) · Diabetes Care · doi:10.2337/diacare.29.02.06.dc05-1963 · Cited by 101
Pathogenesis of glucose intolerance in uremia
DeFronzo, R. A. (1978) · Metabolism · doi:10.1016/s0026-0495(78)80005-5 · Cited by 92
Dissecting the Physiology and Pathophysiology of Glucagon-Like Peptide-1
Paternoster, S., & Falasca, M. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00584 · Cited by 92
Gastrointestinal peptides and insulin secretion
Ebert, R., & Creutzfeldt, W. (1987) · Diabetes/Metabolism Reviews · doi:10.1002/dmr.5610030101 · Cited by 92
Suppression of glucagon secretion is lower after oral glucose administration than during intravenous glucose administration in human subjects
Meier, J. J., Deacon, C. F., Schmidt, W. E., Holst, J. J., & Nauck, M. A. (2007) · Diabetologia · doi:10.1007/s00125-007-0598-z · Cited by 92
Protection of pancreatic beta-cells: Is it feasible?
Bonora, E. (2007) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2007.05.004 · Cited by 90
Disturbed islet-cell function related to endogenous gastrin release. Studies on insulin secretion and glucose tolerance in pernicious anemia.
Rehfeld, J. F. (1976) · Journal of Clinical Investigation · doi:10.1172/jci108457 · Cited by 88
β-cell apoptosis in type 2 diabetes: quantitative and functional consequences
Lupi, R., & Prato, S. D. (2008) · Diabetes & Metabolism · doi:10.1016/s1262-3636(08)73396-2 · Cited by 90
Stimulation of incretin secretion by dietary lipid: is it dose dependent?
Yoder, S. M., Yang, Q., Kindel, T. L., & Tso, P. (2009) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.90601.2008 · Cited by 87
Chronic Pancreatitis: Recent Advances and Ongoing Challenges
Ahmad, S. A., Wray, C. J., Rilo, H., Choe, K. A., Gelrud, A., Howington, J. A., Lowry, A. M., & Matthews, J. B. (2006) · Current Problems in Surgery · doi:10.1067/j.cpsurg.2005.12.005 · Cited by 89
Dipeptidyl peptidase IV (DPP IV) and related molecules in type 2 diabetes
Flatt, P. R. (2008) · Frontiers in bioscience · doi:10.2741/2956 · Cited by 85
Islet adaptation to insulin resistance: mechanisms and implications for intervention
Åhrén, B., & Pacini, G. (2004) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2004.00361.x · Cited by 86
Glucose-Dependent Insulinotropic Polypeptide Confers Early Phase Insulin Release to Oral Glucose in Rats: Demonstration by a Receptor Antagonist
Lewis, J. T., Dayanandan, B., Habener, J. F., & Kieffer, T. J. (2000) · Endocrinology · doi:10.1210/endo.141.10.7750 · Cited by 87
Impaired glucose tolerance and diabetes in obesity: a 6-year follow-up study of glucose metabolism
Jallut, D., Golay, A., Munger, R., Frascarolo, P., Schutz, Y., Jéquier, E., & Felber, J. P. (1990) · Metabolism · doi:10.1016/0026-0495(90)90168-c · Cited by 83
Activation of melatonin signaling promotes β-cell survival and function
Costes, S., Boss, M., Thomas, A. P., & Matveyenko, A. V. (2015) · Molecular Endocrinology · doi:10.1210/me.2014-1293 · Cited by 84
Measurement of the incretin hormones: glucagon-like peptide-1 and glucose-dependent insulinotropic peptide
Kuhre, R. E., Albrechtsen, N. J. W., Hartmann, B., Deacon, C. F., & Holst, J. J. (2014) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2014.12.006 · Cited by 86
Prandial Premixed Insulin Analogue Regimens Versus Basal Insulin Analogue Regimens in the Management of Type 2 Diabetes: An Evidence-Based Comparison
Ilag, L. L., Kerr, L., Malone, J. K., & Tan, M. H. (2007) · Clinical Therapeutics · doi:10.1016/j.clinthera.2007.07.003 · Cited by 84
Effects of Cholecystokinin, Gastric Inhibitory Polypeptide, and Secretin on Insulin and Glucagon Secretion in Rats*
SZECOWKA, J., Lins, P. E., & Efendić, S. (1982) · Endocrinology · doi:10.1210/endo-110-4-1268 · Cited by 83
DPP4 Inhibitors: a new approach in diabetes treatment
Doupis, J., & Veves, A. (2008) · Advances in Therapy · doi:10.1007/s12325-008-0076-1 · Cited by 83
Insulin production rate, hepatic insulin retention and splanchnic carbohydrate metabolism after oral glucose ingestion in hyperinsulinaemic Type 2 (non-insulin-dependent) diabetes mellitus
Waldhäusl, W. K., Bratusch-Marrain, P. R., Gasic, S., Korn, A., & Nowotny, P. (1982) · Diabetologia · doi:10.1007/bf00257722 · Cited by 80
Physiology and Emerging Biochemistry of the Glucagon-Like Peptide-1 Receptor
Willard, F. S., & Sloop, K. W. (2012) · Experimental Diabetes Research · doi:10.1155/2012/470851 · Cited by 84
Exendin 4 controls insulin production in rat islet beta cells predominantly by potentiation of glucose-stimulated proinsulin biosynthesis at the translational level
Alarcon, C., Wicksteed, B. L., & Rhodes, C. J. (2006) · Diabetologia · doi:10.1007/s00125-006-0433-y · Cited by 82
Slowly and rapidly digestible starchy foods can elicit a similar glycemic response because of differential tissue glucose uptake in healthy men
Eelderink, C., Schepers, M., Preston, T., Vonk, R. J., Oudhuis, L. A. A. C. M., & Priebe, M. G. (2012) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.112.041947 · Cited by 79
Mechanisms of insulin resistance in man
Rizza, R. A., Mandarino, L. J., & Gerich, J. E. (1981) · The American Journal of Medicine · doi:10.1016/0002-9343(81)90423-x · Cited by 79
Oral Glucose Tolerance and Related Factors in a Normal Population Sample—II. Interrelationship of Glycerides, Cholesterol, and other Factors with the Glucose and Insulin Response
Abrams, M. E., Jarrett, R. J., KEEN, H., Boyns, D. R., & Crossley, J. N. (1969) · BMJ · doi:10.1136/bmj.1.5644.599 · Cited by 79

Authors: Perley, M. J., & Kipnis, D. M.
Affiliations: Washington University in St. Louis (US)
Venue: Journal of Clinical Investigation
Publisher: American Society for Clinical Investigation
Published: 1967-12-01
Volume: 46
Issue: 12
Pages: 1954-1962
ISSN: 0021-9738 (ISSN-L)
DOI: 10.1172/jci105685
PMC: PMC292948
OpenAlex: W2169558934
Cited by: 917
References: 24
Citations by year: 2026: 12 · 2025: 12 · 2024: 15 · 2023: 17 · 2022: 12 · 2021: 16 · 2020: 20 · 2019: 25 · 2018: 15 · 2017: 15 · 2016: 28 · 2015: 33 · 2014: 13 · 2013: 25 · 2012: 16
FWCI: 60.63
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: Journal of Clinical Investigation (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
Keywords: insulin secretion, oral glucose tolerance, intravenous glucose, obesity, type 2 diabetes, hypersecretion, insulin resistance
MeSH terms: Adolescent, Adult, Aged, Arteries, Capillaries, Child, Diabetes Mellitus, Glucose, Humans, Infusions, Parenteral, Insulin, Middle Aged, Obesity, Veins

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Plasma Insulin Responses to Oral and Intravenous Glucose: Studies in Normal and Diabetic Subjects*

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks